A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

NCT06922084 Phase 4 RECRUITING

Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.

Details

Lead sponsor	Berkeley Eye Center
Phase	Phase 4
Status	RECRUITING
Enrolment	320
Start date	2025-03-17
Completion	2026-04

Conditions

• Cataract

Interventions

• Clareon PanOptix
• Clareon PanOptix PRO
• Mix-and-Match PanOptix/Vivity

Primary outcomes

• Binocular photopic CDVA (corrected distance visual acuity) — 3 months postoperatively

Countries

United States